The Clorox Company (NYSE:CLX) has been a prime focus in the recent market trade. Shares ownership has seen significant changes; Wellington Management Group LLP and Worldquant Millennium Advisors LLC have sold their shares, while Quantinno Capital Management LP, Franklin Resources Inc, Public Employees Retirement System of Ohio, Kovitz Investment Group Partners and others boosted their position. Barclays PLC and Quantbot Technologies LP also reduced their position in the company. Concurrently, CLX stock outperformed its competitors on certain trading days, but also underperformed on others. Notably, the company has seen a 20.5% gain over the past six months, hitting a 52-week high. The firm's Q1 2025 earnings surpassed estimates, while recording a modest recovery in market share. This led to a raised FY25 view, making CLX a favorable stock with a consistent
Dividend payout. The company has also progressed with sustainable practices, earning Barron's Most Sustainable U.S. Company accolade for a second successive year. It has also been recognized by the EPA as a 2024 Safer Choice Partner. CLX completed the divestiture of its Better Health VMS Business, and announced an
Partnership with M2030 to benefit climate action.
Clorox Company CLX News Analytics from Thu, 01 Feb 2024 08:00:00 GMT to Sat, 21 Dec 2024 09:10:27 GMT -
Rating 7
- Innovation 2
- Information 6
- Rumor 3
